Published in Curr Drug Targets on June 01, 2005
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes (2009) 2.80
Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med (2006) 2.59
RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation? J Alzheimers Dis (2009) 1.31
Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis (2009) 1.29
Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior. Acta Biomater (2012) 1.22
Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med (2009) 1.19
Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice. Arterioscler Thromb Vasc Biol (2008) 1.10
Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators Inflamm (2012) 1.02
Methylglyoxal mediates adipocyte proliferation by increasing phosphorylation of Akt1. PLoS One (2012) 0.90
The metal chelators, trientine and citrate, inhibit the development of cardiac pathology in the Zucker diabetic rat. Exp Diabetes Res (2009) 0.86
Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetes. Br J Pharmacol (2008) 0.84
Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment. Cardiovasc Diabetol (2013) 0.83
In vitro antidiabetic potential of the fruits of Crataegus pinnatifida. Res Pharm Sci (2015) 0.81
Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen. Br J Pharmacol (2009) 0.79
The inhibitory activities of the edible green alga Capsosiphon fulvescens on rat lens aldose reductase and advanced glycation end products formation. Eur J Nutr (2013) 0.78
Regenerative therapies for diabetic microangiopathy. Exp Diabetes Res (2012) 0.78
Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complication. Int J Health Sci (Qassim) (2016) 0.78
Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease? J Alzheimers Dis (2016) 0.77
Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis. Int J Mol Sci (2017) 0.76
Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis. Int J Biomed Sci (2013) 0.75
Relationship between Dietary Fat Intake, Its Major Food Sources and Assisted Reproduction Parameters. J Reprod Infertil (2014) 0.75
Luteolin alleviates methylglyoxal-induced cytotoxicity in osteoblastic MC3T3-E1 cells. Cytotechnology (2016) 0.75
Analysis of advanced glycation end products in the DHS Mind Study. J Diabetes Complications (2015) 0.75
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes (1999) 5.96
Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem (2000) 3.17
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int (1999) 2.87
The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem (1996) 2.42
Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest (1993) 2.40
Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem (1986) 2.36
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Diabetologia (2010) 2.35
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28
N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J (1997) 2.25
Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem (1991) 2.22
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest (2001) 2.20
N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry (1995) 2.19
Taste genes associated with dental caries. J Dent Res (2010) 2.17
Diabetes and hypertension. Australian Diabetes Society position statement. Med J Aust (1995) 2.14
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest (1993) 2.03
Effect of glycosylation on the in vivo circulating half-life of ribonuclease. J Biol Chem (1976) 1.97
Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry (1995) 1.97
Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med (2000) 1.91
Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest (1998) 1.90
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia (2011) 1.90
Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. J Biol Chem (1979) 1.89
Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation (1998) 1.87
Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry (1991) 1.75
Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis (2005) 1.71
Reduced bone mass in daughters of women with osteoporosis. N Engl J Med (1989) 1.70
PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int (2001) 1.69
Developmental expression of ACE2 in the SHR kidney: a role in hypertension? Kidney Int (2006) 1.68
Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids (2003) 1.62
The Amadori product on protein: structure and reactions. Prog Clin Biol Res (1989) 1.61
Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes (1994) 1.58
Enamel formation genes are associated with high caries experience in Turkish children. Caries Res (2008) 1.57
Tuftelin, mutans streptococci, and dental caries susceptibility. J Dent Res (2005) 1.57
Blockade of the renin-angiotensin and endothelin systems on progressive renal injury. Hypertension (2000) 1.56
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia (2003) 1.55
Oxidation of glycated proteins: age-dependent accumulation of N epsilon-(carboxymethyl)lysine in lens proteins. Biochemistry (1989) 1.53
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia (2011) 1.51
The role of a dolichol-oligosaccharide as an intermediate in glycoprotein biosynthesis. Proc Natl Acad Sci U S A (1974) 1.50
[3H]Raffinose, a novel radioactive label for determining organ sites of catabolism of proteins in the circulation. J Biol Chem (1979) 1.49
The effect of alpha-mannose-terminal oligosaccharides on the survival of glycoproteins in the circulation. Rapid uptake and catabolism of bovine pancreatic ribonuclease B by nonparenchymal cells of rat liver. Arch Biochem Biophys (1978) 1.49
Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J (1997) 1.48
The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia (1995) 1.46
Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int (1999) 1.46
The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest (1999) 1.45
Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry (1995) 1.45
Carbohydrate-mediated clearance of antibody . antigen complexes from the circulation. The role of high mannose oligosaccharides in the hepatic uptake of IgM . antigen complexes. J Biol Chem (1980) 1.45
Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J Biol Chem (1998) 1.45
Limitations of cognitive status exams: a case-based discussion. Psychiatry (1996) 1.43
Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J (2000) 1.43
Nonenzymatic glucosylation of rat albumin. Studies in vitro and in vivo. J Biol Chem (1979) 1.42
Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes (1994) 1.40
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes. Med J Aust (2001) 1.39
Letter: Death of a pioneer. Vet Rec (1974) 1.39
Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug. Diabetologia (2003) 1.39
Nonenzymatic glucosylation and glucose-dependent cross-linking of protein. J Biol Chem (1983) 1.39
Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats. Kidney Int (1998) 1.36
Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery. J Perinatol (2007) 1.36
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging (1996) 1.35
Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension (2000) 1.35
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol (2001) 1.35
Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci U S A (1979) 1.32
Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia (1984) 1.31
Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes (1991) 1.30
The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels. J Nucl Med (1994) 1.30
Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes (2007) 1.29
The role of mannosyl-phosphoryl-dihydropolyisoprenol in the synthesis of mammalian glycoproteins. J Biol Chem (1973) 1.29
Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest (1998) 1.29
Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia (2005) 1.28
MSX1 and TGFB3 contribute to clefting in South America. J Dent Res (2003) 1.28
Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest (1991) 1.26
Chemical modification of proteins by methylglyoxal. Cell Mol Biol (Noisy-le-grand) (1998) 1.26
Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry (1990) 1.24